CFTR modulators represent a turning point in the therapeutic approach to CF and have radically changed its nature by evolving from being an option for a niche of CF patients to representing a key therapeutic option beyond all expectations for the majority of CF patients, with increasingly promising results. The gene discussed is CFTR; the disease is cystic fibrosis.